Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology crawled date : 2021 - 10 - 27 save search
Vanda Pharmaceuticals to Announce Third Quarter 2021 Financial Results on November 3, 2021
Published: 2021-10-27 (Crawled : 23:00) - biospace.com/
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: -1.33%
H: 1.69%
C: 0.34%
financial results results
Precigen to Host R&D Update Virtual Event on November 4th to Share Clinical Developments
Published: 2021-10-27 (Crawled : 23:00) - biospace.com/
PGEN | $1.33 1.53% 1.5% 1.1M
|
Health Technology
|
| O: -0.43%
H: 1.31%
C: -1.75%
Checkmate Pharmaceuticals Announces CEO TransitionAlan Fuhrman, experienced biotech executive and Checkmate board member, appointed as interim President and CEO
Published: 2021-10-27 (Crawled : 23:00) - biospace.com/
CMPI | $10.5 0.0%
|
Health Technology
|
| O: -0.0%
H: 1.96%
C: -3.91%
biotech ceo iot leo
TYME Technologies, Inc. to Host Conference Call and Webcast on Monday, November 8th at 8:30 AM ET
Published: 2021-10-27 (Crawled : 23:00) - biospace.com/
TYME | $0.3107 -8.21%
|
Health Technology
|
| O: 1.69%
H: 0.0%
C: -2.03%
conference
PPD Reports Third Quarter and Year-To-Date 2021 Results
Published: 2021-10-27 (Crawled : 23:00) - biospace.com/
TMO | News | $541.52 -1.05% 0.61% 2.1M
|
Health Technology
|
| O: 0.78%
H: 1.49%
C: -0.73%
CG | $43.69 -2.11% -2.15% 2.8M
|
Finance
|
| O: -0.34%
H: 0.21%
C: -1.75%
results
Innoviva Reports Third Quarter 2021 Financial Results
Published: 2021-10-27 (Crawled : 23:00) - biospace.com/
INVA | $14.69 1.45% 1.43% 640K
|
Health Technology
|
| O: 0.25%
H: 1.19%
C: 0.94%
financial results results
CONMED Corporation Announces Third Quarter Financial Results
Published: 2021-10-27 (Crawled : 23:00) - biospace.com/
CNMD | $71.08 -2.31% 0.0% 620K
|
Health Technology
|
| O: -0.37%
H: 0.04%
C: -2.27%
CNMD | $71.08 -2.31% 0.0% 620K
|
Health Technology
|
| O: -0.37%
H: 0.04%
C: -2.27%
financial results results
Supernus to Announce Third Quarter 2021 Financial Results and Host Conference Call on November 3, 2021
Published: 2021-10-27 (Crawled : 23:00) - globenewswire.com
SUPN | $28.88 -0.41% -0.42% 350K
|
Health Technology
|
| O: 2.5%
H: 0.48%
C: -1.91%
financial results results conference
Precigen to Host R&D Update Virtual Event on November 4th to Share Clinical Developments
Published: 2021-10-27 (Crawled : 21:00) - prnewswire.com
PGEN | $1.33 1.53% 1.5% 1.1M
|
Health Technology
|
| O: 0.22%
H: 10.2%
C: 9.98%
USD 2 Billion Growth expected in Clinical Staffing Services Market by 2024 | 1,200+ Sourcing and Procurement Report | SpendEdge
Published: 2021-10-27 (Crawled : 21:00) - prnewswire.com
ICLR | $291.74 -0.1% -0.1% 500K
|
Health Technology
|
| O: 0.51%
H: 1.33%
C: 1.15%
growth
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for Phase 1/1b Clinical Trial of ITK Inhibitor CPI-818 in ChinaCPI-818 clinical trial in China will be conducted by Angel Pharmaceuticals
Published: 2021-10-27 (Crawled : 21:00) - biospace.com/
CRVS | $1.43 5.15% 4.9% 140K
|
Health Technology
|
| O: -2.45%
H: 5.25%
C: 4.11%
phase 1 china trial approval
Align Technology Announces Record Third Quarter 2021 Financial Results
Published: 2021-10-27 (Crawled : 21:00) - biospace.com/
ALGN | $301.35 0.4% 0.4% 420K
|
Health Technology
|
| O: -0.34%
H: 4.05%
C: 2.22%
financial results results technology
Volumetric to Be Acquired by 3D Systems to Advance Tissue and Organ Manufacturing
Published: 2021-10-27 (Crawled : 21:00) - biospace.com/
DDD F | $3.47 2.36% 0.0% 1.6M
|
Producer Manufacturing
|
| O: -0.73%
H: 3.82%
C: -5.09%
UTHR | $237.16 0.79% 0.78% 480K
|
Health Technology
|
| O: -0.42%
H: 0.11%
C: -1.85%
acquired
Alnylam Reports Positive Topline 18-Month Results from HELIOS-A Phase 3 Study of Vutrisiran in Patients with hATTR Amyloidosis with Polyneuropathy
Published: 2021-10-27 (Crawled : 21:00) - biospace.com/
ALNY | News | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -0.42%
H: 0.24%
C: -3.2%
positive results topline phase 3
Dyadic to Report Third Quarter 2021 Financial Results on Wednesday, November 10, 2021
Published: 2021-10-27 (Crawled : 21:00) - globenewswire.com
DYAI A | $1.605 -4.46% -4.67% 37K
|
Health Technology
|
| O: 0.71%
H: 2.82%
C: -0.24%
financial results results
Brickell Biotech Announces Proposed Underwritten Public Offering of Common Stock
Published: 2021-10-27 (Crawled : 21:00) - globenewswire.com
BBI | $2.12 16.04%
|
Health Technology
|
| O: -26.37%
H: 6.46%
C: 1.14%
offering biotech iot publication
FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
Published: 2021-10-27 (Crawled : 20:00) - fda.gov
TMO | News | $541.52 -1.05% 0.61% 2.1M
|
Health Technology
|
| O: 0.44%
H: 2.01%
C: 0.82%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 2.03%
H: 3.33%
C: 0.07%
RGNX | $16.08 -5.58% -5.91% 560K
|
Health Technology
|
| O: 0.91%
H: 2.93%
C: 2.79%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.19%
H: 2.32%
C: 1.7%
disease fda gene therapies therapy gene therapy rare
Viking Therapeutics to Report Financial Results for Third Quarter 2021 on November 3, 2021
Published: 2021-10-27 (Crawled : 20:00) - prnewswire.com
VKTX | $64.7 -2.66% -2.74% 2.4M
|
Health Technology
|
| O: -0.68%
H: 3.28%
C: 2.93%
LGND | $72.61 -7.94% -8.62% 130K
|
Health Technology
|
| O: 0.31%
H: 5.06%
C: 4.98%
financial results results
BioMarin Announces Third Quarter 2021 Financial Results and Corporate Updates
Published: 2021-10-27 (Crawled : 20:00) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.83%
H: 1.2%
C: 0.32%
BMRN S | $90.08 -0.43% -0.43% 940K
|
Health Technology
|
| O: 2.48%
H: 6.83%
C: 6.39%
financial results results
Inventiva announces the design of LEGEND, a Phase IIa combination trial with lanifibranor and SGLT2 inhibitor empagliflozin in patients with NASH and type 2 diabetes
Published: 2021-10-27 (Crawled : 20:00) - inventivapharma.com
IVA | $3.28 1.86% 1.83% 12K
|
Health Technology
|
| O: -1.03%
H: 1.25%
C: 0.24%
diabetes nash trial designation
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.